NYSE
260.85USD
-3.66 (-1.38%)
We have scored 24 news catalysts on Tenet Healthcare Corporation (THC) over the past 12 months. The biggest single-day move next to one of them came Jul 25, 2026, when THC closed +17.2%: “Tenet Healthcare's Ambulatory Growth Offsets Emerging Policy Headwinds”. Coverage across the window leans positive (average ticker sentiment +0.39). Most of the impact sits in sector healthcare and earnings revision trend.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
21B
P/E
—
EPS
—
Beta
1.23
52W range
157.58-283.05
Day range
258.20–263.76
Open
262.90
Prev close
264.51
Volume
518.7K
Avg volume
1.2M
Dividend
0.00
IPO
1980-03-17
Analysts publish price targets on THC, and they disagree. Where the share price actually sits among them shows which of their arguments the market is buying — and which it is ignoring.
15 analyst price targets from $231 to $308
as of 2026-09-05
The market is within 6% of the median target — broadly agreeing with the analysts.
The reconstruction
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Tenet Healthcare Corporation — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for THC: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Tenet Healthcare Corporation operates as a broad-ranging provider of health solutions. The company organizes its operations across three main divisions: Hospital Operations and Other, Ambulatory Care, and Conifer. Within its network of acute care facilities, Tenet delivers a full spectrum of essential services. These include core hospital functions such as operating and recovery suites, radiology and respiratory therapy, clinical laboratories, and on-site pharmacies. The organization also provides high-acuity patient care through intensive, critical, and coronary care units. Specialized medical services cover areas like cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics, alongside various outpatient treatments, including physical therapy. Advanced surgical capabilities feature cardiothoracic, complex spinal, and neurosurgery, as well as neonatal intensive care. Tenet extends its offerings to ultra-specialized quaternary care, exemplified by heart and kidney transplant programs, and sophisticated procedures such as limb-salvaging vascular interventions, acute Level 1 trauma care, intravascular stroke treatment, minimally invasive cardiac valve replacements, advanced imaging, and telemedicine access. Beyond its hospital network, Tenet manages numerous other clinical sites. These encompass outpatient surgical centers, immediate care facilities, diagnostic imaging centers, dedicated surgical hospitals, off-campus emergency departments, and micro-hospitals. Through its Conifer segment, the company furnishes critical healthcare business process solutions. These administrative services, offered to hospitals, health systems, physician practices, employers, and other clients, include financial administration for patient accounts (revenue cycle management), support for patient communications and engagement, and outcome-focused care strategies. As of February 9, 2022, Tenet's operational footprint included 60 hospitals and roughly 550 additional medical facilities. This count of additional sites comprises surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and various other clinical locations. Tenet Healthcare Corporation was established in 1975 and maintains its principal office in Dallas, Texas.
The price sits at the 13th percentile of the published model spread, roughly agreeing with the eight endorsed targets near $280 and explicitly refusing to pay for the three bull-case models 15-16% above it.
What the disagreement turns on
Can the Ambulatory Care segment sustain or accelerate its volume growth above the 10-14% range the price already pays for, and the available data can partially settle this by measuring unit volumes.
The price pays for
It declines to pay for
Written by a language model from the published models, the reported segments and a reverse-DCF — not a recommendation, and not a house view.
Claim by claim
